Filmmaker Srijit Mukherji on Wednesday responded to charges levelled by actor-producer Dev a day earlier over alleged denial ...

Under the agreement, Biocon will supply semaglutide to Ajanta for exclusive marketing in 23 countries and semi-exclusive ...

Rail Vikas Nigam (RVNL) board approved the appointment of Saleem Ahmad as chairman & managing director with effect from 23 December 2025. Mumbai, Dec. 24 -- Securities in F&O Ban: ...

Hindustan Copper hits new high, Tata Capital settles SEBI case, Ola Electric and Ajanta Pharma in focus amid a flat market ...

Pharmaceutical stocks are back in focus with strong stock-specific triggers. Ajanta Pharma has gained attention after signing a licensing agreement with Biocon to market Semaglutide across 26 ...

Under the agreement, Biocon will supply semaglutide to Ajanta Pharma for exclusive marketing in 23 countries Shares of Ajanta ...

Ajanta Pharma share price rose as it has entered into an in-licensing agreement with Biocon Limited for the right to market ...

Semalutide improves glycaemic control in adults. The product patent expires in most these markets in March 2026. Ajanta ...

New Delhi: Biotech firm Biocon on Tuesday said it has signed an out-licensing agreement with Ajanta Pharma to market its ...

Mumbai-based Ajanta Pharma has entered into an agreement with Biocon to commercialise its version of semaglutide across select emerging markets. The announcement was made after market hours on Tuesday ...

As India marks 80 years of the UN, the AIKYAM 2025 event at the UNESCO-listed Ellora caves highlights heritage as the country’s powerful asset ...

Emcure Pharmaceuticals has informed the exchanges that the United States Food and Drug Administration (USFDA) has issued a No ...